Effects of nabilone, a synthetic cannabinoid, on postoperative painBEAULIEU, Pierre.Canadian journal of anaesthesia. 2006, Vol 53, Num 8, pp 769-775, issn 0832-610X, 7 p.Article

Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and Δ⁹-tetrahydrocannabinol in anesthetized catsDOHERTY, P. A; MCCARTHY, L. E; BORISON, H. L et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 227, Num 2, pp 508-516, issn 0022-3565Article

Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : A double-blind placebo-controlled cross-over trialWISSEL, Jörg; HAYDN, Tanja; MULLER, Jörg et al.Journal of neurology. 2006, Vol 253, Num 10, pp 1337-1341, issn 0340-5354, 5 p.Article

The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)FRASER, George A.CNS neuroscience & therapeutics (Print). 2009, Vol 15, Num 1, pp 84-88, issn 1755-5930, 5 p.Article

THE PHARMACOLOGIC PROFILE OF NABILONE: A NEW ANTIEMETIC AGENT = PROFIL PHARMACOLOGIQUE DU NABILONE: UN NOUVEL ANTIEMETIQUESTARK P.1982; CANCER TREATMENT REVIEWS; ISSN 0305-7372; GBR; DA. 1982-12; VOL. 9; SUPPL.; PP. 11-16; BIBL. 10 REF.; GRAPH, FIGArticle

The abuse potential of the synthetic cannabinoid nabiloneWARE, Mark A; ARNAUD-TREMPE, Emmanuelle St.Addiction (Abingdon. Print). 2010, Vol 105, Num 3, pp 494-503, issn 0965-2140, 10 p.Article

The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled TrialWARE, Mark A; FITZCHARLES, Mary-Ann; JOSEPH, Lawrence et al.Anesthesia and analgesia. 2010, Vol 110, Num 2, pp 604-610, issn 0003-2999, 7 p.Article

La nabilone (Cesamet -USA) contre les nausées et vomissements induits par la chimiothérapie = Nabilone for chemotherapy-induced nausea and vomitingThe Medical letter on drugs and therapeutics (Edition française). 2007, Vol 29, Num 1-2, pp 7-8, issn 0253-8512, 2 p.Article

CLINICAL PHARMACOLOGY OF NABILONE, A CANNABINOL DERIVATIVE. = PHARMACOLOGIE CLINIQUE DE LA NABILONE, UN DERIVE DU CANNABINOLLEMBERGER L; ROWE H.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 6; PP. 720-726; BIBL. 11 REF.Article

Effects of the synthetic cannabinoid nabilone on spatial learning and hippocampal neurotransmissionDIANA, Giovanni; MALLONI, Massimiliano; PIERI, Massimo et al.Pharmacology, biochemistry and behavior. 2003, Vol 75, Num 3, pp 585-591, issn 0091-3057, 7 p.Article

A Randomized, Double-Blinded, Crossover Pilot Study Assessing the Effect of Nabilone on Spasticity in Persons With Spinal Cord InjuryPOOYANIA, Sepideh; ETHANS, Karen; SZTURM, Tony et al.Archives of physical medicine and rehabilitation (Print). 2010, Vol 91, Num 5, pp 703-707, issn 0003-9993, 5 p.Article

Lack of interference by nabilone in the EMIT^® d.a.u. cannabinoid assay, Abbott TDx^® cannabinoid assay, and a sensitive TLC assay for △⁹-THC-carboxylic acidFRASER, A. D; MEATHERALL, R.Journal of analytical toxicology. 1989, Vol 13, Num 4, issn 0146-4760, 240Article

Thermospray collisionally induced dissociation with single and multiple mass analyzersMCFADDEN, W. H; GARTEIZ, D. A; SIEGMUND, E. G et al.Journal of chromatography. 1987, Vol 394, Num 1, pp 101-108, issn 0021-9673Conference Paper

A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapyNIIRANEN, A; MATTSON, K.American journal of clinical oncology. 1985, Vol 8, Num 4, pp 336-340, issn 0277-3732Article

Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugsCUNNINGHAM, D; FORREST, G. J; SOUKOP, M et al.British medical journal (1857). 1985, Vol 291, Num 6499, pp 864-865, issn 0007-1447Article

EFFETTI IPOTENSIVI OCULARI DI UN CONNABINOIDE SINTETICO: IL NABILONE: NOTA PRELIMINARE = EFFETS HYPOTENSEURS OCULAIRES D'UN CANNABINOIDE DE SYNTHESE: LA NABILONE. NOTE PRELIMINAIRED'ERMO F; GEROSA LT.1980; BOLL. OCUL.; ISSN 0006-677X; ITA; DA. 1980; VOL. 59; NO 1-2; PP. 99-104; ABS. ENG; BIBL. 9 REF.Article

SUPPRESSION OF CANCER CHEMOTHERAPY-INDUCED VOMITING IN THE CAT BY NABILONE, A SYNTHETIC CANNABINOIDLONDON SW; MCCARTHY LE; BORISON HL et al.1979; PROC. SOC. EXPER. BIOL. MED.; USA; DA. 1979; VOL. 160; NO 4; PP. 437-440; BIBL. 11 REF.Article

SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTIEMETIC IN PATIENTS RECEIVING CANCER CHEMOTHERAPYHERMAN TS; EINHORN LH; JONES SE et al.1979; NEW ENGL. J. MED.; USA; DA. 1979; VOL. 300; NO 23; PP. 1295-1297; BIBL. 17 REF.Article

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain : randomised, crossover, double blind studyFRANK, B; SERPELL, M. G; HUGHES, J et al.BMJ. British medical journal (International ed.). 2008, Vol 336, Num 7637, pp 199-201, issn 0959-8146, 3 p.Article

The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitationPASSMORE, Michael J.International journal of geriatric psychiatry. 2008, Vol 23, Num 1, pp 116-117, issn 0885-6230, 2 p.Article

Cannabinoids in bipolar affective disorder : a review and discussion of their therapeutic potentialASHTON, C. H; MOORE, P. B; GALLAGHER, P et al.Journal of psychopharmacology (Oxford). 2005, Vol 19, Num 3, pp 293-300, issn 0269-8811, 8 p.Article

NABILONE: A POTENT ANTIEMETIC CANNABINOL WITH MINIMAL EUPHORIA.HERMAN TS; JONES SE; DEAN J et al.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 27; NO 9-10; PP. 331-334; ABS. FR.; BIBL. 8 REF.Article

SOLID DISPERSION APPROACH FOR OVERCOMING BIOAVAILABILITY PROBLEMS DUE TO POLYMORPHISM OF NABILONE, A CANNABINOID DERIVATIVE.THAKKAR A; HIRSCH CA; PAGE JG et al.1977; J. PHARM. PHARMACOL.; G.B.; DA. 1977; VOL. 29; NO 12; PP. 783-784; BIBL. 5 REF.Article

NABILONE: AN EFFECTIVE ANTIEMETIC AGENT IN PATIENTS RECEIVING CANCER CHEMOTHERAPY = LA NABILONE: UN ANTIEMETIQUE EFFICACE CHEZ LES MALADES TRAITES POUR UN CANCER, PAR CHIMIOTHERAPIEEINHORN L.1982; CANCER TREATMENT REVIEWS; ISSN 0305-7372; GBR; DA. 1982-12; VOL. 9; SUPPL.; PP. 55-61; GRAPHArticle

THE EFFECTS OF DELTA ⁹-TETRAHYDROCANNABINOL AND NABILONE ON THE ISOLATED GUINEA PIG BRONCHUSO'NEIL RMO; GOODMAN FR; FORNEY RB et al.1980; TOXICOL. APPL. PHARMACOL.; USA; DA. 1980; VOL. 54; NO 3; PP. 493-500; BIBL. 25 REF.Article